Search - tctmd.com

Displaying 81 - 100 of 254

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

News Daily News

Long-Term Outcomes Similar for CABG vs DES in Women with Left Main Disease

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

News Daily News

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

L.A. McKeown

February 17, 2014

News Industry News

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

February 13, 2014

News Daily News

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

January 22, 2014

News Daily News

Second-Generation DES the Better Choice for STEMI Patients

December 09, 2013

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

News Industry News

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

October 30, 2013

News Conference News TCT 2013

PCI vs. CABG a Close Call in Some Complex Patients

October 30, 2013

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Presenter: Piotr Buszman

October 28, 2013

News Conference News TCT 2013

Cre8, BioFreedom Polymer-Free DES Show Promise

October 28, 2013

News Daily News

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Leah Lawrence

October 25, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

Un Balón liberador de Fármacos Supera a la Angioplastia en el Tratamiento de la Reestenosis intra Stent

Jason Kahn

September 27, 2013

Advertisement

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

Long-Term Outcomes Similar for CABG vs DES in Women with Left Main Disease

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Meta-analysis: IVUS-Guided Stent Placement Improves Outcomes vs Angiography

Zilver PTX randomized trial of paclitaxel-eluting stents for femoropopliteal disease demonstrates superior results

RIBS V Published: Good Outcomes with DEB, EES for BMS In-stent Restenosis Patients

Second-Generation DES the Better Choice for STEMI Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

STENTYS Self-Apposing Stent Performs Well in New Coronary Indications

PCI vs. CABG a Close Call in Some Complex Patients

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon Plus Bare Metal Stents vs. Paclitaxel-Eluting Stents for De Novo Coronary Lesions

Cre8, BioFreedom Polymer-Free DES Show Promise

SYNTAX: Stent Thrombosis Has Greater Impact on Mortality Than Graft Occlusion

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

Un Balón liberador de Fármacos Supera a la Angioplastia en el Tratamiento de la Reestenosis intra Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content